We compared patient-controlled epidural analgesia (PCEA) with patient-controlled intravenous analgesia (PCIA) using pethidine or fentanyl in a randomized, double-blind crossover study of 80 patients after caesarean section. Patients received pethidine by PCEA or PCIA, or fentanyl by PCEA or PCIA, with a crossover of the route of administration at 12 h.
Patient-controlled analgesia (PCA) is effective for postoperative pain relief after caesarean section and may be delivered intravenously (patient-controlled intravenous analgesia, PCIA) 1 or epidurally (patientcontrolled epidural analgesia, PCEA) 2 . Potential advantages of PCEA over PCIA include better analgesia, lower drug consumption, and a lower incidence of side-effects. These advantages may differ between opioids in current usage. In particular, it has been suggested that there may be minimal advantages of PCEA over PCIA when highly lipid-soluble opioids are used 3 . This randomized, double-blind, crossover study compared PCEA with PCIA for postoperative analgesia after caesarean section using fentanyl or pethidine, opioids which are commonly used for epidural analgesia but which differ in lipid solubility.
METHODS
After obtaining approval from the local Clinical Research Ethics Committee, we studied 80 ASA physical status 1-2 Asian women undergoing elective caesarean section under epidural anaesthesia. All patients gave written informed consent and were instructed in the use of a 100 mm visual analog scale (VAS) and a patient-controlled analgesia (PCA) device. Premedication was ranitidine 150 mg the night before and the morning of surgery and 0.3 M sodium citrate 30 ml on arrival in the operating theatre. An epidural catheter was inserted in the L2-3 or L3-4 interspace and lignocaine 2% with adrenaline 1:200,000 was injected to establish block to the T4 dermatome. Intraoperative pain was treated with nitrous oxide by facemask or 10 mg intravenous increments of ketamine as required. The epidural catheter was cleared of local anaesthetic by flushing with 2 ml normal saline after completion of surgery. After arrival in the recovery room, patients were randomized by drawing of shuffled coded envelopes to receive one of four analgesic regimens: pethidine by PCIA for 12h followed by PCEA for 12h (group Peth-I/E), pethidine PCEA followed by PCIA (group Peth-E/I), fentanyl PCIA followed by PCEA (group Fent-I/E) or fentanyl PCEA followed by PCIA (group Fent-E/I). PCA solution containing either pethidine 10 mg.ml -1 or fentanyl 20 µg.ml -1 was prepared by an anaesthetist not involved in patient assessment. These concentrations gave the same dose ratio used in previous comparisons of epidural pethidine and fentanyl 4, 5 . The PCA device (Abbott Pain Management Provider, Abbott Laboratories, North Chicago, IL 60064, U.S.A.) was then connected to both the epidural catheter and the intravenous catheter by means of a concealed three-way stopcock which was set to direct flow via the initial assigned route. The epidural filter was primed with 1 ml of solution before connection.
At patients' first request for pain relief, a loading dose of 4 ml PCA solution was given over 2 min. PCA was made available after 15 min (bolus dose 2 ml, lockout interval 6 min, 4 h maximum dose 40 ml). Nursing observation was continued throughout the period of PCA according to our standard protocol of hourly measurement of respiratory rate and conscious level. Patient assessments were performed immediately before the loading dose and at 3, 6, 9, 12, 15, 30 min, and 1, 4, 8, 12, 16, 20 , 24h after the loading dose. At each assessment patients were asked to grade pain, nausea, dizziness, and pruritus at rest using the VAS and sedation was assessed on a 4-point scale (1=alert, 2=awake but drowsy, 3=asleep, easy to rouse, 4=asleep, difficult to rouse). Patients were woken if necessary to complete assessments. In 37 consenting patients (nine in groups Peth-I/E, Peth-E/I, Fent-I/E and ten in group Fent-E/I), an extra intravenous cannula was inserted into a forearm vein on the side opposite to the intravenous infusion and blood samples were taken immediately before the loading dose and at 3, 6, 9, 12, 15, 30 min and 1, 8, 12, 20 and 24 h after the loading dose for subsequent measurement of plasma concentrations of pethidine and norpethidine, or fentanyl. Samples were immediately centrifuged and the plasma stored at -70°C before assay. Pethidine and norpethidine were measured using a modified gas chromatography method 6 . The calibration curves for the assay were linear over the ranges 50-3000 ng.ml -1 (pethidine) and 25-500 ng.ml -1 (norpethidine). The coefficients of variation for between-day variation for pethidine at 100 ng.ml -1 and 500 ng.ml -1 were 7.0% and 5.7% respectively, and for norpethidine at 50 ng.ml -1 and 250 ng.ml -1 were 13.5% and 9.4% respectively. The coefficients of variation for within-day variation for pethidine at 100 ng.ml -1 and 500 ng.ml -1 were 13.0% and 3.6% respectively, and for norpethidine at 50 ng.ml -1 and 250 ng.ml -1 were 6.2% and 9.9% respectively. The limit of sensitivity was 10 ng.ml -1 for both pethidine and norpethidine. Fentanyl was measured using radioimmunoassay using a commercially available kit 7 . The calibration curve for the assay was linear over the range 0.05-4 ng.ml -1 . The coefficients of variation for between-day variation at 0.25 ng.ml -1 and 1.0 ng.ml -1 were 13.1% and 7.0% respectively and the coefficients of variation for within-day variation at 0.25 ng.ml -1 and 1.0 ng.ml -1 were 9.0% and 2.6% respectively. The limit of sensitivity was 0.1 ng.ml -1 .
After 12 h, the PCA route was changed by rotation of the three-way stopcock. After 24 h, patients were asked if they preferred the first or second modality. Details of PCA usage were obtained from the memory of the PCA device.
The Kruskal-Wallis test was used to compare patient characteristics and lignocaine dose between all groups. The Mann-Whitney U test was used to compare pain scores, PCA demands, drug consumption, maximum side-effect scores, and plasma concentrations of pethidine, norpethidine or fentanyl between individual pairs of groups. Binomial probability functions were used to analyse patient preference for PCEA or PCIA. P<0.05 was considered statistically significant. All analyses were made using Statview for Windows 4.53 (Abacus Concepts, Inc) on an IBM compatible computer.
RESULTS
Data were analysed from 79 patients who completed the study. One patient in group Fent I/E was excluded because of technical problems with the PCA device. A second patient in group Fent I/E was withdrawn from the study after 4 h because of inadequate analgesia; data from this patient were included until the time of withdrawal. The epidural block was inadequate for surgery in three patients who required general anaesthesia. These patients had not yet been randomized and three further patients were enrolled as replacements. There were no differences in patient characteristics or use of intraoperative drugs between groups ( Table 1) .
Onset of pain relief was faster after intravenous loading doses than after epidural loading doses, as shown by lower pain scores at 3 min and 6 min in groups Peth-I/E and Fent-I/E than in groups Peth-E/I and Fent-E/I respectively ( Figure 1 ). However, by 9 min pain scores were similar. Subsequently, in the remainder of the first hour after the loading dose, pain scores were lower (for pethidine at 60 min and for fentanyl at 30 min and 60 min) and patients made fewer PCA demands in the epidural groups than in the intravenous groups ( Table 2 ). Intravenous loading doses resulted in higher plasma opioid concentrations ( Figure 2 ), and greater dizziness ( Table 3 ). There were no differences in pain scores or side-effects between groups Peth-I/E and Fent-I/E or between groups Peth-E/I and Fent-E/I. Pain scores after first hour are shown in Figure 3 .
For pethidine, pain scores in the first 12 h period were lower with PCEA (group Peth-E/I) compared with PCIA (group Peth-I/E) at every assessment; after crossover, pain scores were lower with PCEA (group Peth-I/E) at 16 h but subsequently the difference was not significant. For fentanyl, pain scores in the first 12 h period were lower with PCEA (group Fent-E/I) at 12h; after crossover there was no significant difference. Comparing pethidine and fentanyl, there were no differences in pain scores between group Peth-I/E and group Fent I/E, or between group Peth-E/I and group Fent-I/E. Total PCA demands and drug consumption are Side-effects are summarized in Table 5 . There were no differences in aggregate side-effect scores in either 12 h period for PCEA vs PCIA. When data from groups Peth-I/E and Peth-E/I and groups Fent-I/E and Fent-E/I were combined, there were no differ- Data are aggregates of eight visual analog scores (median (interquartile range)) for nausea, pruritus and dizziness or four-point scores (median (interquartile range)) for sedation in the first hour following the loading dose. There were no differences when pethidine and fentanyl groups were compared. ences in side-effects for PCEA vs PCIA. When pethidine groups were compared with equivalent fentanyl groups, there were no difference in side-effects although there was a trend (P=0.05) towards greater pruritus group in Fent-I/E vs group Peth I/E in the second 12 h period. There was one instance of a sedation score of 4, in group Peth-I/E at 16 h. This was not associated with respiratory depression and required no treatment.
Patients' preference for PCEA or PCIA is shown in Table 6 . For pethidine, more patients preferred PCEA than PCIA (P=0.015), whereas for fentanyl, patients had similar preference for either technique (P=0.4). Seventeen patients replied that they had no preference.
Plasma concentrations of pethidine, norpethidine and fentanyl after the first hour are shown in Figure  4 . Plasma concentrations of fentanyl were greater in group Fent-I/E compared with group Fent-E/I at 12 h (P=0.002) but were similar at other times. Plasma concentrations of pethidine were similar between groups Peth-I/E and Peth-E/I. Plasma concentrations of norpethidine increased with time and were similar between groups Peth-I/E and Peth-E/I ( Figure 5 ).
DISCUSSION
Patient-controlled analgesia enables patients to titrate drug use against pain and side-effects, and provides a useful method for comparison of drugs and routes of administration. Differences may be seen in quality of analgesia, PCA demand rates, drug consumption and side-effects. In this study, doubleblinding was used to compare the intravenous route with the epidural route for pethidine and fentanyl. However, some patients may have been aware of the sensation of epidural injection and some patients found intravenous injection irritating or painful after Plasma Concentration of Pethidine (ng.ml -1) a number of hours. Changing the route of administration at 12 h enabled patients to make a subjective comparison of the two routes of administration. Some carryover effects can be expected in this type of crossover design, but these might reasonably be expected to continue only into the first few hours after crossover and are unlikely to have influenced patients' final assessments 12 h later. A previous study of PCEA after caesarean section using pethidine suggested that pain intensity did not change over the first 24 h postoperatively 8 . However, in our study, for both pethidine and fentanyl the total drug consumption for combined groups was lower in the second 12 h compared with the first 12 h. This suggests that pain intensity did decrease during the study period and limits intrapatient comparisons before and after crossover. Onset of analgesia was faster with intravenous compared with epidural loading doses. However, the greater incidence of dizziness which was associated with higher plasma drug concentrations after intravenous loading probably outweighs this advantage. Pain scores later in the first hour were lower in the epidural groups than in the intravenous groups, despite similar or lower plasma drug concentrations, which suggests that both drugs had spinal sites of action.
After the first hour, for pethidine we found PCEA maintained advantages over PCIA throughout the study period. These advantages consisted of lower pain scores for a similar drug consumption in the first 12 h period, and lower pain scores at 16 h and lower total drug consumption in the second 12 h period for PCEA compared with PCIA. For fentanyl, the advantages of PCEA were clearly demonstrable only in the first 12 h period when drug consumption and the 12 h pain scores were lower compared with PCIA. In the second 12 h period we were unable to demonstrate advantages of PCEA. It has been suggested previously that a significant component of the analgesia from epidural fentanyl is mediated by systemic effects 3, 9 . Our findings support fentanyl having the advantages of a spinal site of action in the initial period of the study, but suggest that these advantages were not sustained with time, although there was a trend (P=0.05) towards lower drug consumption compared with PCIA in the second 12 h period.
Plasma concentrations of fentanyl were lower for PCEA vs PCIA group at 12 h. This was during the period when fentanyl consumption was lower for PCEA vs PCIA. For pethidine, drug consumption in the second 12 h period was lower for PCEA vs PCIA but we could not demonstrate a difference in plasma concentrations of pethidine. This may reflect the effects of accumulation of drug; however, the small numbers of patients from whom blood samples were taken means that our study had limited power to detect small differences.
The differences we found between pethidine and fentanyl most likely relate to differences in lipid solubility. Fentanyl has high lipid solubility (octanol/pH 7.4 buffer partition coefficient 813) 10 . This means that fentanyl is rapidly absorbed into fat and has a short duration of action. In comparison, pethidine has intermediate lipid solubility (octanol/pH 7.4 buffer partition coefficient 39) 10 . A longer duration of action of both epidural and intravenous pethidine would explain the lower rate of PCA demands in the pethidine groups compared with the corresponding fentanyl groups. Alternatively, this could reflect an inequality of the doses of pethidine and fentanyl used. However, similar analgesia after the loading doses suggests that the drugs were given in approximately equipotent ratios. Intravenous fentanyl undergoes rapid redistribution 11 and a particularly short duration of action of intravenous fentanyl might explain the marked difference in drug consumption between the fentanyl PCEA and PCIA groups in the first 12 h period that was not seen with pethidine.
Paech et al 8 compared PCEA and PCIA after caesarean section using pethidine in a similar crossover study and found lower pain scores, drug consumption and plasma concentrations of pethidine with PCEA compared to PCIA at all assessment times. The difference in our findings might be explained by the difference in the concentration of pethidine in the PCA solutions. We diluted pethidine to 10 mg.ml --1 which is similar to that used in other reports of PCEA after caesarean section using pethidine 12 . Paech et al used the same size PCA bolus (20 mg), but with a lower concentration (4 mg.ml --1 vs 10 mg.ml --1 ) and larger volume (5 ml vs 2 ml). Subsequent to the completion of this study we found that the efficacy of epidural pethidine was reduced when a dose of 25 mg was given in a volume of 2 ml compared with 5 ml 13 . In addition, racial and cultural factors may have had an influence: compared with European patients, Asian patients made fewer PCA demands and consumed less opioid, despite similar pain scores, in a comparative study of postoperative analgesic requirements 14 . This would explain why both the PCA demand rate and total pethidine consumption were lower in our patients compared to the patients studied by Paech et al. Paech et al found patients receiving PCIA had higher sedation scores compared with patients receiving PCEA. We did not confirm this in our study, perhaps because our fourpoint observer scale was not as sensitive as the visual analog scale used by Paech et al. 15 compared PCEA and PCIA using fentanyl after caesarean section and found that pain scores at rest were lower in the PCEA group compared with the PCIA group at 24 h. The difference from our study might also be explained by their use of a higher volume/lower concentration of fentanyl (20 µg/5ml) compared with our study (40 µg/2ml). Dilution of epidural fentanyl 50 µg to a volume of 5 ml or greater was shown to improve analgesia 16 . Nevertheless, in the study by Cooper et al, total fentanyl consumption was similar between groups and pain scores on coughing were similar between groups at 24 h, indicating that the advantages of PCEA may have been reducing at this time. Cooper et al used a less liberal PCA prescription which would explain the lower total drug consumption and higher resting pain scores, particularly in the PCIA group, compared with our study.
Cooper et al
Goh et al 5 compared pethidine with fentanyl in a crossover study of PCEA after caesarean section in which patients received each drug for 24h. Although there were no differences in pain scores between the two drugs, and similar to our study, no significant difference in side-effects in the first 24 h, pethidine had advantages of giving greater patient satisfaction compared with fentanyl and was preferred by patients over fentanyl. Our findings support the conclusion by Goh et al that pethidine has advantages over fentanyl for PCEA since we found that patients preferred PCEA over PCIA with pethidine, but not with fentanyl. Patients in our study receiving PCEA made fewer PCEA demands in the second 12 h period, despite a lower PCEA dose, compared with patients in the study by Goh et al. This is consistent with the difference in drug consumption between our patients and the patients in the study by Paech et al, and probably also reflects cultural and ethnic differences between the populations studied. Goh et al continued their study for 48 h whereas the majority of our patients requested cessation of PCA after 24h and thereafter requested only oral analgesia.
In summary, we found that the epidural route for PCA had advantages over the intravenous route for both pethidine and fentanyl. However, for fentanyl we were unable to demonstrate that the advantages of PCEA were still present at 24 h. Patients preferred PCEA over PCIA with pethidine, but not with fentanyl. Pethidine has advantages over fentanyl for PCEA after caesarean section.
